Personen

TOP 5 Publikationen:

1. Wetzel L, Hoffmann S, Reinhard I, Riegler A, Pourbaix M, Ardern I, Link T, Vollstädt-Klein S, Lenz B, Kiefer F, Bach P, Koopmann A. Glucose intake reduces alcohol craving and amplifies habituation to cue-induced brain activation in male patients with alcohol use disorder: A randomized, placebo-controlled crossover study examining male and female patients with AUD.Psychoneuroendocrinology. 2025 177:107456.
2. Vollstädt-Klein S, Türkmen C, Grundinger N, Wieland A, Aggensteiner PM, Stock AK, Stein M, Moggi F, Bublatzky F, Kiefer F, Link T, Gerhardt S. Modification of inhibitory control and craving through transcranial direct current stimulation as an add-on treatment for substance use disorder: protocol for a randomized controlled study.BMC Psychol. 2025 13(1):1132.
3. Wetzel L, Hoffmann S, Reinhard I, Riegler A, Pourbaix M, Ardern I, Link T, Vollstädt-Klein S, Lenz B, Kiefer F, Koopmann A, Bach P. Glucose Intake Reduces Craving in Patients with Alcohol Use Disorder Depending on Insulin Response.Eur Addict Res. 2025 31(4):251-263.
4. Vetter S, Weinberg J, Thomas BC, Kirchner M, Thalmann P, Klose C, Pfisterer M, Kölsch T, Oesterle S, Vollstädt-Klein S, Koopmann A, Lenz B, Kiefer F, Link T, Bach P. Investigation of the combined effects of cannabidiol plus naltrexone on alcohol craving in alcohol dependence: study protocol of a phase II randomised, double-blind, placebo-controlled, parallel-group trial - ICONICplus Trial.BMJ Open. 2025 15(8):e106348.
5. Zimmermann US, Plickert C, Lüdecke C, Stuppe M, Rosenbeiger C, Krisam Y, Link T, Keller J, Bühler G, Scholz-Hehn D, Havemann-Reinecke U, Wedekind D, Luderer M, Spreer M. [Patient and quality characteristics in the treatment with disulfiram (Antabus) in the German "Network for Alcohol Aversive Pharmacotherapy"].Nervenarzt. 2025 96(2):159-165.